Keywords: astrazeneca, 4th-qtr, results, lower, line, expectations, uk

AstraZeneca 4th-qtr results lower, but in line with expectations

Article | 02 February 2004

• Print This

UK drug major AstraZeneca has reported fourth-quarter 2003 sales of $4.87 billion, down a marginal 1%, or 8% lower at constant exchange rates. Operating ...

Enjoying this article? To continue reading you need to login or subscribe.